VxP Pharma offers over 100 well-characterized Tumor Cell Line Xenograft models. Our team has extensive experience working with some of the world’s largest pharma companies, as well as many small and virtual companies. We offer custom development of multiple models to help you achieve your goals.
Some of our Xenograft Models are as follows:
| Cancer Type | Human Cancer Cell Lines |
|---|---|
| Head and Neck | FaDu, Detroit 562, CAL-27 |
| Oral Epithelial Carcinoma | KB |
| Lung Cancer | DMS114, NCI-H69, NCl-H146, NCl-H209, NCI-H446, NCI-H526, NCI-H1688, 95-D, A549, Calu-1, Calu-3, Calu-6, HCC827, NCI-H226, NCI-H292, NCI-H358, NCI-H441, NCI-H460, NCI-H520, NCI-H522, NCI-H1299, NCI-H1437, NCI-H1650, NCI-H1975, NCI-H1993, NCI-H2009, NCI-H2122, NCI-H2126, NCI-H2228, PC-10, QG-56, A427, H23, H1568, H2110 |
| Breast Cancer | SUM159, MDA-MB-231, MDA-MB-468, Bcap-37, 2LMP, ZR-75-1, ZR-75-30, HCC70, HCC1954, MDA-MB-361, MCF-7, BT474 |
| Gastric Cancer | MKN-45, NCI-N87, BGC-823, HGC-27, MKN-28, NUGC-3, SCH, SGC-7901, SNU-5, SNU-16, MGC-803 |
| Pancreatic Cancer | AsPC-1, BxPC-3, Capan-1, Capan-2, CFPAC-1, HPAF-II, MIAPaCa-2, PANC-1, PANC-10.05 |
| Renal Cancer | ACHN, OS-RC-2, 786-O, A498 |
| Hepatocellular Carcinoma | Bel-7402, Hep-3B, Huh-7, PLC/PRF/5, QGY-7703, SK-HEP-1, SMMC-7721, HepG-2, JHH7 |
| Glioblastoma | U87-MG |
| Colon and Cecum Cancer | COLO 201, COLO 205, COLO 320 DM, CW-2, DLD-1, HCT-8, HCT-15, HCT-116, HT-29, LoVo, LS1034, LS174T, LS411N, NCI-H716, RKO , SW48, SW620, WiDr, SW948, DiFi |
| Prostate Cancer | DU145,PC-3, LNCap, CL-1, |
| Urinary Bladder | HT-1197, HT-1376, RT4, SCaBER, SW780, T24 |
| Ovarian Cancer | ES-2, HO-8910PM, PA-1, SK-OV-3, OVCAR-3 |
| Endometrium/Hysterocarcinoma | AN3 CA, HEC-1-A, ME-180, MFE-280 |
| Cervical cancer | SiHa, Hela |
| Skin Cancer | A431, Colo829 |
| Melanoma | A375, A2058, C32, HMCB, SK-MEL-30, MDA-MB-435s, WM-226-4 |
| Osteosarcoma | MG-63, SJSA-1 |
| Fibrosarcoma | HT-1080 |
| Muscle, Striated | SJCRH30 |
| Myeloma | KMS-11, KMS-26, RPMI-8226 ,MM.1S |
| Leukemia / Lymphoma | U937, THP-1, MV-4-11, HEL, TF-1a, ML-2, HL-60, K562, KARPAS-299, Daudi, RL, Mino, Raji, Ramos, ARH-77, KMS-12-BM, KG-1, JeKo-1, MAVER-1, CML-T1, MOLM-13, TMD-8, OCI-LY10, Nalm-6 |
Tumor Cell Line Xenograft models are excellent predictors of the cytotoxicity of cancer drugs, and are extensively used in efficacy studies. The benefits of xenograft models include overall simplicity, as well as easy access for tumor measurement.
VxP currently offers a wide range of Xenograft models derived from human cancer cell lines. Please contact us if you would like to learn more.